Outset Medical Inc OM.OQ OM.O is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025
The San Jose California-based company is expected to report a 1.3% decrease in revenue to $27.812 million from $28.17 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Outset Medical Inc is for a loss of 94 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had fallen by about 0.6% in the last three months.
Wall Street's median 12-month price target for Outset Medical Inc is $15.00, above its last closing price of $12.25.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | -6.15 | -6.19 | -5.55 | Beat | 10.3 |
Sep. 30 2024 | -6.37 | -6.33 | -5.85 | Beat | 7.5 |
Jun. 30 2024 | -6.76 | -6.78 | -7.05 | Missed | -4.1 |
Mar. 31 2024 | -8.47 | -8.23 | -8.55 | Missed | -3.9 |
Dec. 31 2023 | -9.20 | -9.22 | -8.85 | Beat | 4.1 |
Sep. 30 2023 | -9.98 | -10.00 | -10.65 | Missed | -6.5 |
Jun. 30 2023 | -12.53 | -11.44 | -13.50 | Missed | -18 |
Mar. 31 2023 | -11.68 | -11.13 | -13.50 | Missed | -21.3 |
This summary was machine generated May 5 at 20:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。